Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd.’s Net Profit Rose 232.8% in First Three Quarters of 2022

Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (北京万泰生物药业股份有限公司) (603392.SH) reported a net profit of 4 billion yuan in the first three quarters of 2022, up 232.8% year-on-year.

Meanwhile, the company posted 8.7 billion yuan in revenue, up 140.6% year-on-year.

At the end of the reporting period, it had 15.2 billion yuan in total assets and 3.5 billion yuan in total liabilities, with a liability-to-asset ratio of 22.8%.